Table 1.

Patient demographics a

PatientGenderAge (yr)ESRD DxDuration on PD (mo)ABW (kg)IBW (kg)Height (cm)BSA (m2)24-Hour Urine (ml)Cefazolin (mg)Tobramycin (mg)
aESRD, end-stage renal disease ; Dx, diagnosis ; PD, peritoneal dialysis ; ABW, actual body weight ; IBW, ideal body weight ; BSA, body surface area ; DM, diabetes mellitus ; GN, glomerulonephritis ; PKD, polycystic kidney disease ; X, no drug given.
AF51DM5910354162.32.2900150061.8
BM41GN1212372.5177.32.5Anuric180073.8
CM38GN368969.8174.32.1450130053.2
DM44GN7011679.9185.42.4Anuric170069.6
EM47DM57659.3162.61.8600110045.6
FF38PKD57856.5165.11.9950120046.8
GM50DM69163.8167.62.1650X56
HF57DM37151.91601.8280110042.6
IF31GN37049.6157.51.880110042
JM40PKD37791.4198.12.1AnuricX46.2
Mean43.720.289.464.91712.1391135053.8
SD7.725.518.913.512.90.3373.8282.811.3